Industry Press Releases

Annual Biomarkers and Precision Medicine USA Congress

Wednesday, May 16, 2018

Following on from the success of last year's congress, join us for the 3rd Annual Biomarkers and Precision Medicine USA Congress as we explore the hottest topics and latest innovations in drug discovery and development.

The two-day congress brings together 250+ delegates to discuss novel developments in pre-clinical biomarker research, precision medicine, clinical biomarkers development, companion and clinical diagnostics development. Hear from and meet with the key innovators in biomarker research from Merck, AstraZeneca, Genentech, Pfizer, GSK, Eli Lilly, Kite Pharma, Medimmune and J&J.


Discover predictive and safety biomarker research strategies. Speakers include:
Stefan Kostense, Director Prevention Biomarkers, Janssen Keith Tanis, Principal Scientist, Merck & Co., Inc
Ajit Dash, Safety Science Associate Medical Director, Licensing and Early Development (LEAD) Safety – Non Oncology, Genentech

Gain key insights into the implementation of biomarkers in clinical development and trial design. Speakers include:

Stefan Scherer, Vice President, Global Head Correlative Science, Novartis
Alessandra Di Bacco, Sr. Director, Oncology Global Medical Affairs, Takeda
Deepak Khatry, Science Associate Director, Statistical Sciences, Medimmune


Learn about Scientific and Regulatory Considerations for the Analytical Validation of Clinical

Assays for the Qualifications of Biomarkers in our 2018 workshop.
Co-located with our fast-emerging Advances in Immuno-Oncology USA Congress, this is the event for professionals looking to stay ahead!

For further information on how to save on your attendance and what discounts we have available please contact

Notes to editors
1. Angela Fernandez Saez, +44 1865 248455
2. Oxford Global Conferences, +44 1865 248455.
3. Godstow Court, 5 West Way, Oxford OX2, Oxford, UKPart 1st Floor Godstow Court, Minns Business Park, Botley, Oxford, OX2 0JB

Other Press Releases